We are live on ! Find out more
SURF

Surface Oncology, Inc. Common Stock
SURF

Delisted

SURF was delisted on the 7th of September, 2023.

Back to rankings

91 hedge funds and large institutions have $182M invested in Surface Oncology, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more call options, than puts

Call options by funds: $3.17M | Put options by funds: $1.44M

57% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 21

9% more capital invested

Capital invested by funds: $168M → $182M (+$14.5M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5% less funds holding

Funds holding: 96 → 91 (-5)

23% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 22

Holders
91
Holders Change
-5
Holders Change %
-5.21%
% of All Funds
1.59%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
33
Reduced
21
Closed
22
Calls
$3.17M
Puts
$1.44M
Net Calls
+$1.73M
Net Calls Change
+$1.18M

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$5.82M
2
Goldman Sachs
Goldman Sachs
New York
+$2.77M
3
Wells Fargo
Wells Fargo
California
+$2.22M
4
Marshall Wace
Marshall Wace
United Kingdom
+$1.49M
5
AIM
ARK Investment Management
Florida
+$895K

Top Sellers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$2.31M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.2M
3
WP
Woodline Partners
California
-$1.47M
4
GCP
GSA Capital Partners
United Kingdom
-$859K
5
BlackRock
BlackRock
New York
-$768K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIM
1
ARK Investment Management
Florida
$35M +$895K +139,808 +3%
AVAI
2
Atlas Venture Associates IX
Massachusetts
$22.3M – – –
BlackRock
3
BlackRock
New York
$18.4M -$768K -119,990 -5%
Citadel Advisors
4
Citadel Advisors
Florida
$11M -$2.2M -343,445 -19%
Vanguard Group
5
Vanguard Group
Pennsylvania
$9.15M +$88.2K +13,789 +1%
Goldman Sachs
6
Goldman Sachs
New York
$9.08M +$2.77M +432,647 +56%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$7.74M – – –
FCM
8
Farallon Capital Management
California
$7.57M – – –
O
9
OrbiMed
New York
$6.89M +$5.82M +909,666 New
Morgan Stanley
10
Morgan Stanley
New York
$5.28M -$233K -36,452 -5%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$4.61M +$744K +116,236 +24%
State Street
12
State Street
Massachusetts
$3.81M +$428K +66,905 +15%
Wells Fargo
13
Wells Fargo
California
$2.67M +$2.22M +346,235 +5,072%
Macquarie Group
14
Macquarie Group
Australia
$2.65M – – –
Victory Capital Management
15
Victory Capital Management
Texas
$2.6M -$19.6K -3,070 -0.9%
Northern Trust
16
Northern Trust
Illinois
$2.22M +$38.8K +6,068 +2%
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$2.01M -$2.31M -360,849 -58%
PHP
18
Parkman Healthcare Partners
Connecticut
$1.88M +$128K +20,000 +9%
Stifel Financial
19
Stifel Financial
Missouri
$1.87M +$558K +87,230 +55%
Deutsche Bank
20
Deutsche Bank
Germany
$1.78M +$1.85K +289 +0.1%
Marshall Wace
21
Marshall Wace
United Kingdom
$1.76M +$1.49M +232,162 New
Bank of New York Mellon
22
Bank of New York Mellon
New York
$1.72M +$430K +67,243 +42%
Prudential Financial
23
Prudential Financial
New Jersey
$1.7M +$790K +123,410 +122%
ACM
24
ACT Capital Management
Pennsylvania
$1.29M – – –
Principal Financial Group
25
Principal Financial Group
Iowa
$1.2M -$15.6K -2,439 -2%
1
2 3 4 5

SURF Hedge Fund Activity: Q3 2021 in Review

91 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Surface Oncology, Inc. Common Stock (SURF) for Q3 2021, worth a combined $182M — up 8.7% from $168M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of SURF and 17 opened new positions — a net loss of 5 holders — while 21 trimmed existing stakes and 33 added.

The largest buyer was OrbiMed, opening a new position worth an estimated $5.82M. The largest seller was Dimensional Fund Advisors, cutting an estimated $2.31M.

  • 91 institutional investors held Surface Oncology, Inc. Common Stock (SURF) as of Q3 2021, down from 96 in Q2 2021.
  • Funds reported $182M of Surface Oncology, Inc. Common Stock stock for Q3 2021, up 8.7% quarter-over-quarter.
  • 17 funds opened new Surface Oncology, Inc. Common Stock positions in Q3 2021 and 22 closed out, a net change of -5 holders.
  • The largest Surface Oncology, Inc. Common Stock buyer in Q3 2021 was OrbiMed, an estimated $5.82M added.
  • The largest Surface Oncology, Inc. Common Stock seller in Q3 2021 was Dimensional Fund Advisors, an estimated $2.31M sold.

Based on aggregated 13F filings for Q3 2021.